Ferroportin-1 in the recurrence of hepatic iron overload after liver transplantation

Digestive and Liver Disease

Volumn 41, Issue 7, 2009, Pages

  Valenti, L ^a   Guido, M ^b   Dongiovanni, P ^a   Cremonesi, L ^c   Fracanzani, A L ^a   Fargion, S ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cirrhosis; Ferroportin 1; Hepatitis C virus; Iron overload; Liver transplantation

Indexed keywords

ALPHA INTERFERON; CYCLOSPORIN; FERROPORTIN 1; FOLIC ACID; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RIBAVIRIN;

ADULT; ANEMIA; ARTICLE; CASE REPORT; DISEASE COURSE; DNA POLYMORPHISM; DRUG WITHDRAWAL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON OVERLOAD; KIDNEY FAILURE; KUPFFER CELL; LIVER CIRRHOSIS; LIVER HEMOSIDEROSIS; LIVER TRANSPLANTATION; MALE; MONOCYTE; NEUTROPENIA; PHLEBOTOMY; PRIORITY JOURNAL; RECURRENT DISEASE;

CATION TRANSPORT PROTEINS; HEMOSIDEROSIS; HEPATITIS C, CHRONIC; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MONOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE;

EID: 67349123414     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.01.020     Document Type: Article

References (14)

1. Valenti L., Pulixi E., Arosio P., Cremonesi L., Biasiotto G., Dongiovanni P., et al. Relative contribution of iron genes, dysmetabolism and HCV in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 92 (2007) 1037-1042
2. Guyader D., Thirouard A.S., Erdtmann L., Rakba N., Jacquelinet S., Danielou H., et al. Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C. J Hepatol 46 (2007) 587-595
3. Ludwig J., Hashimoto E., Porayko M.K., Moyer T.P., and Baldus W.P. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 112 (1997) 882-888
4. Guillygomarc'h A., Mendler M.H., Moirand R., Laine F., Quentin V., David V., et al. Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 35 (2001) 344-349
5. Barry M., and Sherlock S. Measurement of liver iron concentration in needle biopsy specimens. Lancet 1 (1971) 100-103
6. Fargion S., Valenti L., Dongiovanni P., Scaccabarozzi A., Fracanzani A.L., Taioli E., et al. Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood 97 (2001) 3707-3712
7. Liu X.B., Yang F., and Haile D.J. Functional consequences of ferroportin 1 mutations. Blood Cells Mol Dis 35 (2005) 33-46
8. Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology 46 (2007) 1291-1301
9. Ng I.O., Chan K.L., Shek W.H., Lee J.M., Fong D.Y., Lo C.M., et al. High frequency of chimerism in transplanted livers. Hepatology 38 (2003) 989-998
10. Zaahl M.G., Merryweather-Clarke A.T., Kotze M.J., van der Merwe S., Warnich L., and Robson K.J. Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload. Hum Genet 115 (2004) 409-417
11. Trombini P., Pelucchi S., Fumagalli Maldini F., Salvioni A., Riva A., Mariani R., et al. HFE and SLC40A1 polymorphisms in patients with unexplained iron overload. J Hepatol 44 (2006) S246
12. Galli A., Bergamaschi G., Recalde H., Biasiotto G., Santambrogio P., Boggi S., et al. Ferroportin gene silencing induces iron retention and enhances ferritin synthesis in human macrophages. Br J Haematol 127 (2004) 598-603
13. Wang F., Paradkar P.N., Custodio A.O., McVey Ward D., Fleming M.D., Campagna D., et al. Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice. Nat Genet 39 (2007) 1025-1032
14. Fillebeen C., Muckenthaler M., Andriopoulos B., Bisaillon M., Mounir Z., Hentze M.W., et al. Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells. J Hepatol 47 (2007) 12-22